199 related articles for article (PubMed ID: 22035661)
21. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
22. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience in breast irradiation with intensity modulated photon beams.
Cozzi L; Fogliata A; Nicolini G; Bernier J
Acta Oncol; 2005; 44(5):467-74. PubMed ID: 16118080
[TBL] [Abstract][Full Text] [Related]
24. A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra-target-tissue irradiation.
Gerardina S; Edy I; Sonia S; Cristina DV; Carla Germana R; Diego G; Michele F; Lucio T; Maria DR; Sara R
Br J Radiol; 2016 Sep; 89(1065):20160039. PubMed ID: 27355127
[TBL] [Abstract][Full Text] [Related]
25. [Acute skin toxicity in breast intensity modulated radiotherapy using field in field technique].
Blanchecotte J; Ruffier-Loubière A; Reynaud-Bougnoux A; Barillot I
Cancer Radiother; 2015 Apr; 19(2):82-8. PubMed ID: 25623257
[TBL] [Abstract][Full Text] [Related]
26. The prone technique for breast irradiation - is it ready for clinical trials?
McKinnon R; Christie D; Peres H; Burke M; Le T; Lah M
Breast; 2009 Feb; 18(1):30-4. PubMed ID: 19010679
[TBL] [Abstract][Full Text] [Related]
27. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects.
Polgár C; Fodor J; Major T; Takácsi-Nagy Z; Kásler M; Hammer J; Van Limbergen E; Németh G
Strahlenther Onkol; 2002 Nov; 178(11):597-606. PubMed ID: 12426670
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy.
van der Laan HP; Dolsma WV; Maduro JH; Korevaar EW; Hollander M; Langendijk JA
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1018-23. PubMed ID: 17379440
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
Zhang F; Zheng M
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
[TBL] [Abstract][Full Text] [Related]
31. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
Richards GM; Berson AM; Rescigno J; Sanghavi S; Siegel B; Axelrod D; Bernik S; Scarpinato V; Mills C
Ann Surg Oncol; 2004 Aug; 11(8):739-46. PubMed ID: 15249336
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
[TBL] [Abstract][Full Text] [Related]
33. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
[TBL] [Abstract][Full Text] [Related]
34. Radioprotective effect of moderate wine consumption in patients with breast carcinoma.
Morganti AG; Digesù C; Panunzi S; De Gaetano A; Macchia G; Deodato F; Cece MG; Cirocco M; Di Castelnuovo A; Iacoviello L; Valentini V; Cellini N; de Gaetano G
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1501-5. PubMed ID: 19395196
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
[TBL] [Abstract][Full Text] [Related]
37. Initial outcomes analysis for large multicenter integrated cancer network implementation of intensity modulated radiation therapy for breast cancer.
Bhatnagar AK; Beriwal S; Heron DE; Flickinger JC; Deutsch M; Huq MS; Sontag M; Shogan J
Breast J; 2009; 15(5):468-74. PubMed ID: 19624420
[TBL] [Abstract][Full Text] [Related]
38. Decrease of the lumpectomy cavity volume after whole-breast irradiation affects small field boost planning.
Mohiuddin MM; Nichols EM; Marter KJ; Flannery TW
Med Dosim; 2012; 37(3):339-43. PubMed ID: 22305933
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.
Chen WC; Kim J; Kim E; Silverman P; Overmoyer B; Cooper BW; Anthony S; Shenk R; Leeming R; Hanks SH; Lyons JA
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):14-20. PubMed ID: 21035961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
